Cita APA

Yu, R., Deedigan, L., Albarenque, S. M., Mohr, A., & Zwacka, R. M. (2013). Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects. Nature Publishing Group.

Citación estilo Chicago

Yu, R., L. Deedigan, S M. Albarenque, A. Mohr, y R M. Zwacka. Delivery of STRAIL Variants By MSCs in Combination With Cytotoxic Drug Treatment Leads to P53-independent Enhanced Antitumor Effects. Nature Publishing Group, 2013.

Cita MLA

Yu, R., et al. Delivery of STRAIL Variants By MSCs in Combination With Cytotoxic Drug Treatment Leads to P53-independent Enhanced Antitumor Effects. Nature Publishing Group, 2013.